BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Novagali Pharma 

1 rue Pierre Fontaine
Genavenir IV
Evry    F-91058  France
Phone: 33-1-69-87-40-20 Fax: 33-1-69-87-40-30


SEARCH JOBS



Segment
Drug Delivery





 Company News
Santen Pharmaceutical to Buy Novagali Pharma for $136 Million 9/28/2011 6:50:17 AM    More...
Biotech Novagali Pharma in Takeover Talks, Mulls IPO 4/14/2010 7:06:57 AM    More...
Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 5/5/2009 8:39:26 AM    More...
Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye 4/15/2009 10:22:17 AM    More...
Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma 2/27/2009 9:54:31 AM    More...
Novagali Pharma Completes a EUR15 Million Fund Raising 9/26/2008 6:25:20 AM    More...
Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema 4/24/2008 6:36:47 AM    More...
Novagali Pharma Announces the Launch of Cationorm(R) The Innovative Cationic Emulsion for the Treatment of Dry Eye Symptoms 4/10/2008 7:04:52 AM    More...
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis 6/25/2007 12:27:38 PM    More...
Novagali Pharma Strengthens its Executive Management 6/20/2007 12:05:25 PM    More...
123

//-->